Dengue vaccine - VaxThera
Latest Information Update: 30 Jan 2023
At a glance
- Originator VaxThera
- Class Dengue vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Dengue
Most Recent Events
- 27 Dec 2022 Early research in Dengue (Prevention) in USA (Parenteral) Before December 2022 (VaxThera pipeline, December 2022)
- 27 Dec 2022 VaxThera plans clinical trials in Dengue (Prevention) in USA (Parenteral) (VaxThera pipeline, December 2022)